An independent FDA advisory committee said that the benefits of Pfizer's coronavirus vaccine outweigh the risks, setting the stage for the agency to authorize emergency use of the shot for people 16 and older
The vaccine from Pfizer and its German partner BioNTech is the first Covid-19 shot to undergo FDA review.